Ryvu Therapeutics SA · LS:A1JUH2

Ryvu Therapeutics SA shareholders

Ryvu Therapeutics SA on 6ix: holders from US fund reports. Largest: State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF, Emerging Markets Core Equity 2 Portfolio and State Street(R) SPDR(R) Portfolio Europe ETF. Each with its filing.

Shareholders

HolderSharesValueAs of
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF10,061US$36,830Jun 30, 2026
Emerging Markets Core Equity 2 Portfolio3,875US$15,296Jul 31, 2026
State Street(R) SPDR(R) Portfolio Europe ETF381US$1,395Jun 30, 2026

Ryvu Therapeutics SA insider trades